Mastery EAQ Ch. 13

A  Onset after the age 7 years. Learning disability with signs of depression. Acting out during school or in the home

B  Onset after the age 7 years. Short attention span for the child’s age. Acting out during school or in the home

C  Lack of ability to control impulses. Symptoms lasting at least 6 months. Short attention span for the child’s age

D  Symptoms lasting at least 6 months. Learning disability with signs of depression. Acting out during school or in the home

A  Dietary intake

B  Pain status

C  Vital signs

D  Activity level

A  Responds to command to use incentive spirometer

B  Carbon dioxide arterial blood gas levels increase

C  Respiratory rate of 16 breaths per minute

D  Pulse of 98 beats per minute

A  Hangover effect

B  Caffeine withdrawal

C  Serotonin syndrome

D  Rebound headache

A  Onset of confusion, History of chronic headache, Blood pressure of 168/94 mmHg, Two previous sumatriptan injections at 0800 and 1200

B  Onset of confusion, Slurred speech, Blood pressure of 168/94 mmHg, Two previous sumatriptan injections at 0800 and 1200

C  Onset of confusion, Slurred speech, History of chronic headache, Two previous sumatriptan injections at 0800 and 1200

D  Onset of confusion, Slurred speech, Blood pressure of 168/94 mmHg, History of chronic headache

A  Schedule III

B  Schedule I

C  Schedule II

D  Schedule IV

A  Diazepam

B  Phenobarbitone

C  Caffeine

D  Morphine

A  Addiction

B  Suicidal tendencies

C  Mood swings

D  Sleeplessness

A  Orlistat

B  Atomoxetine

C  Caffeine

D  Sumatriptan

A  Atomoxetine

B  Dextroamphetamine sulfate

C  Amphetamine aspartate

D  Methylphenidate

A  Postanesthetic respiratory depression and Migraines

B  Bronchopulmonary dysplasia and Migraines

C  End-stage heart failure and Peptic ulcer disease

D  Postanesthetic respiratory depression and Bronchopulmonary dysplasia

A  Relaxes the bronchial smooth muscle. Promotes constriction of the bronchi. Increases the production of surfactant.

B  Relaxes the bronchial smooth muscle. Increases sensitivity to carbon dioxide. Supports a regular pattern of breathing. Blocks the action of cerebral adenosine.

C  Promotes constriction of the bronchi. Blocks the action of cerebral adenosine. Increases the production of surfactant.

D  Promotes constriction of the bronchi. Increases the production of surfactant. Increases sensitivity to carbon dioxide.

A  Modafinil for shift work sleep disorder

B  Atomoxetine for attention-deficit/hyperactivity disorder

C  Dextroamphetamine for narcolepsy

D  Orlistat for weight loss management

A  Early afternoon when restlessness occurs

B  At least 4 hours before bedtime

C  Preceding morning school activities daily

D  Before breakfast on weekdays

A  Increase fluid and fiber in the diet.

B  Limit dietary intake of fat to less than 30% of total calories.

C  Supplement the diet with fat-soluble vitamins.

D  Take the medication with an antacid.

A  Phentermine

B  Modafinil

C  Orlistat

D  Naratriptan

A  Take the medication with a lot of fluids.

B  Do not take phentermine.

C  Take ice chips for relief of headache.

D  Take acetaminophen.

A  Armodafinil

B  Amphetamine aspartate

C  Orlistat

D  Methylphenidate

A  Substance abuse treatment

B  Respiratory therapy

C  Dietary referral

D  Pain management

A  Use deep breathing exercises instead of medication to keep the child calm.

B  Talk to the health care provider about instituting “drug holidays.”

C  Switch the child to caffeine, which is a more natural stimulant.

D  Reduce the dose of the medication slightly.

A  “You should continue to observe the child’s behavior for 4 months.”

B  “You should consult a child psychiatrist immediately.”

C  “Your child has attention-deficit/hyperactivity disorder.”

D  “This is the normal behavior of a 7-year-old child.”

A  “You should follow a nutrition and exercise regimen for weight management.”

B  “Ask the primary health care provider to prescribe an anorexiant because it will reduce obesity.”

C  “Ask the primary health care provider to prescribe an oral hypoglycemic medication.”

D  “You should drink coffee and alcohol once a week to reduce obesity.”

A  The patient has been taking reduced doses of medication.

B  The patient has taken the medication with excess amounts of fluids.

C  The patient has been taking this medication for a long time.

D  The patient has not followed the dosing schedule as prescribed.

A  Methamphetamine

B  Orlistat

C  Phentermine

D  Benzphetamine

A  “This drug causes amenorrhea.”

B  “This drug has a high risk of abuse.”

C  “This drug has many side effects.”

D  “This drug causes hallucinations.”

A  Modafinil

B  Benzphetamine

C  Methylphenidate

D  Atomoxetine

A  Phentermine

B  Almotriptan

C  Dextroamphetamine

D  Caffeine

A  Atomoxetine and orlistat

B  Modafinil and doxapram

C  Doxapram and sumatriptan

D  Modafinil and sumatriptan

A  Avoid dissolving the sustained-release medications in water. Administer the medication after meals. Administer the medication 2 hours before going to bed.

B  Avoid administering medications on weekends. Avoid dissolving the sustained-release medications in water. Administer the medication before sending the child to school.

C  Administer the medication after meals. Administer the medication before sending the child to school. Administer the medication 2 hours before going to bed.

D  Administer the medication after meals. Administer the medication 2 hours before going to bed. Avoid administering medications on weekends.

A  “I will give these drugs 30 to 45 minutes before meals to improve absorption.”

B  “I may dispense these medications to nursing staff if needed.”

C  “It is permissible to crush extended-release medications for patients who have difficulty swallowing pills.”

D  “If I notice side effects of these medications, I should stop giving the drug immediately and notify the provider.”

A  Diarrhea

B  Fecal incontinence

C  Enhanced urinary output

D  Chest congestion

A  Diazepam and Atomoxetine

B  Diazepam and Ergotamine

C  Naratriptan and Zolmitriptan

D  Ergotamine and Sibutramine

A  The patient is taking monoamine oxidase inhibitors (MAOIs).

B  The patient is taking antiviral medications.

C  The patient has glaucoma.

D  The patient has diabetes.

A  Insomnia

B  Bradycardia

C  Hypotension

D  Decreased mental alertness

A  Bradycardia

B  Drowsiness

C  Syncope

D  Increased blood pressure

A  Tingling, Dizziness, Flushing

B  Nasal irritation, Tingling, Flushing

C  Dizziness, Numbness, Nasal irritation

D  Tingling, Flushing, Numbness

A  Nutrition deficiency

B  Hyperglycemia

C  Gastric ulcers

D  Insomnia

A  Dexmethylphenidate induces sedation in the child.

B  Dexmethylphenidate does not improve attention.

C  Dexmethylphenidate has more addictive properties.

D  Dexmethylphenidate is contraindicated in pediatric patients.

A  Pulsating headache, Daytime sleepiness, Skeletal muscle weakness

B  Phonophobia, Daytime sleepiness, Skeletal muscle weakness

C  Photophobia, Phonophobia, Pulsating headache

D  Daytime sleepiness, Photophobia, Skeletal muscle weakness

A  Headache, Increased appetite, Decreased blood pressure

B  Increased appetite, Insomnia, Decreased blood pressure

C  Weight loss, Increased appetite, Decreased blood pressure

D  Insomnia, Headache, Weight loss

A  Headache, Severe hypertension

B  Seizures, Insomnia, Dysrhythmias

C  Headache, Severe hypertension

D  Headache, Severe hypertension

A  Glaucoma, Drug allergies, Bulimia nervosa

B  Hypotension, Bulimia nervosa, Hypothyroidism

C  Hypotension, Hypothyroidism, Glaucoma

D  Drug allergies, Hypotension, Hypothyroidism

A  “They increase the effect of norepinephrine.”

B  “I should not take these medications at least 1 day per week.”

C  “They block the reuptake of dopamine.”

D  “It may decrease my heart rate.”

A  120 mg at each meal

B  20 mg after lunch

C  50 mg as a single dose

D  5 mg before breakfast and lunch

A  Modafinil

B  Sumatriptan

C  Orlistat

D  Dextroamphetamine

A  Ergot alkaloids

B  Lipase inhibitors

C  Serotonin receptor agonists

D  Phosphodiesterase inhibitors

A  Cerebrovascular system

B  Medulla and brainstem

C  Hypothalamic and limbic regions

D  Cerebral cortex

A  Caffeine

B  Aminophylline

C  Doxapram

D  Theophylline

A  32 mg

B  40 mg

C  200 mg

D  100 mg

A  To increase the rate of respiration. To increase the depth of respiration

B  To reduce blood glucose level. To reduce uric acid levels.

C  To reduce uric acid levels. To reduce blood pressure

D  To reduce blood pressure. To reduce blood glucose level.

A  Modafinil

B  Atomoxetine

C  Sumatriptan

D  Phentermine

A  Skeletal muscle weakness

B  High body mass index (BMI)

C  Pulsating headache

D  Hyperactivity

A  Attention-deficit/hyperactivity disorder

B  Narcolepsy

C  Migraine

D  Postanesthetic respiratory depression

A  Phentermine

B  Amphetamine

C  Orlistat

D  Atomoxetine